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Abstract: Galaxolide is the most used fragrance since the early 1990s, and it has been 
largely detected in environmental and biological matrices. This polycyclic musk is present 
in almost all of our daily products, so the risk of human exposure is substantial, as it had 
been proved by its detection in human tissues and fluids. Due to the lack of information 
about the concentrations found in consumer products, monitoring data is needed for 
exposure assessment purposes. Dermal contact, mostly by personal care products, seems to 
be the major route of human exposure to galaxolide, and, due to the immaturity of young 
children’s skin, exposure consequences can be worse in this population. The main 
objective of this study was to evaluate galaxolide levels in personal care products used by 
children of Oporto (Portugal), aged 0–5 years, and relate it with consumer habits. 
Consumer patterns were obtained through 250 questionnaires to caregivers of Oporto 
children. The 79 most used products were extracted by a dispersive solid phase extraction 
methodology known as QuEChERS and galaxolide was determined by High Performance 
Liquid Chromatography (HPLC) with fluorescence detection. The concentrations ranged 
between 0.001 ± 0.001 mg·kg−1, on a baby wipe, and 300.480 ± 8.819 mg·kg−1, on glycerin 
soap, which may correspond to an estimated daily dermal exposure of 277.10 ± 0.02 µg·day−1 
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on the population of Oporto children. This value is in the range of the results observed for 
adults, although no information of toxicological risk for children is available. 
Keywords: galaxolide; dermal exposure risk; children; personal care products; 
QuEChERS; HPLC-fluorescence 
 
1. Introduction 
Musks are synthetic fragrances widely used in innumerous daily products, like personal care 
products (PCP), in order to maintain the desired scent. They are applied as fixatives, because of their 
low volatility against other fragrances, retarding their release. There are four main groups of musks, 
according to their physical–chemical properties: nitro musks (NM), polycyclic musks (PM), 
macrocyclic musks (MM), and alicyclic musks (AM) [1].  
The PM galaxolide (HHCB; 1,3,4,6,7-hexahydro-4,6,6,7,8-hexamethylcyclopenta-γ-2-benzopyran; 
Figure 1) is the most used musk in the world since the early 1990s [2]. 
 
Figure 1. Galaxolide (HHCB) chemical structure. 
Due to the massive use of fragranced PCPs that are frequently water rinsed after application,  
it is expected that 77% of musks are discharged into the sewer system [3]. As HHCB has a high  
octanol-water partition coefficient (log Kow = 5.9) and relatively low water solubility (1.75 mg·L−1), 
this compound has been found in wastewater treatment plants (influents, effluents, and in sewage 
sludge) and even in environmental matrices (surface water, sediments, and suspended matter) [2]. 
HHCB also reaches the biological food chain, and has been detected in several biological matrices, 
most of them aquatic fauna [2,3]. Therefore, the risk of exposure to HHCB by humans is significant, 
not only directly by PCPs and other products (dermal, oral, and inhalation exposure), but also by food 
and the environment. In fact, HHCB has already been found in human tissues and fluids like blood, 
human fat, and breast milk [2,3]. 
The main source of human exposure to musks is expected to be by the dermal application of PCPs, 
especially by leave-on products [3]. Musks have been described as potentially endocrine disrupters, 
although low estrogenic effects have been reported for HHCB in humans at current levels of  
exposure [4]. It has also been reported that perfumes that contain several fragrances, like HHCB,  
may play an important role in inducing genetic mutations that can lead to autism spectrum disorders, 
and the incidence of this disorder has increased in children since the early 1990s [4]. Nevertheless,  
the providing the details of the entire fragrance composition is not legally mandatory in European 
Union, forcing companies to only to refer to “Parfum” or “Aroma” in the product composition [5]. 
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There are more than 2000 known fragrances used in PCPs like perfumes, moisturizers, bath or hair 
care products, or even cosmetic products [6]. But there are also some PCPs with such a residual 
quantity of fragrances that are not referenced in the product’s composition, and can even be labelled as 
“fragrance-free”, namely some children or baby PCPs. 
Children’s skin is different from adults’ skin, because after birth, and during the first months or 
years of life, the cutaneous structure and functions are in adaptation and maturation [7,8]. At this age, 
the skin barrier, that prevents the loss of water and the penetration of irritants or allergens,  
is less developed than in adults [9], mainly due to the lack of some lipids, higher levels of water and 
pH [10,11]. Additionally, the cutaneous permeability can be altered, for example, by the use of soaps 
and detergents that can raise skin pH, especially in newborn babies [9]. So, the use of PCPs in children 
can damage the skin barrier, allowing allergens to enter through the skin [9–11]. Consequently, 
depending on some predisposing factors and also on the presence of certain PCP ingredients, such as 
fragrances, children’s skin is more vulnerable to adverse reactions like atopic eczema, chemical dermal 
allergies and hypersensitivity [7–9], or even absorption into the bloodstream. A study in the elderly 
population, which also have the epidermal barrier altered, showed higher systemic absorption of musks 
than in healthy adults [12], but no studies were found in children. So, children’s dermal exposure risk 
to HHCB may be higher than in adults and no data is available regarding the use of PCPs by this 
population. The maturation process of skin may be beyond the first year of life [10], and this should be 
taken into account when choosing the population under scrutiny. 
Few reports refer to the detection of HHCB in PCPs themselves, even in the ones targeting adults. 
The reported HHCB concentrations ranged from below 0.003 to 22,000 mg·kg−1 [3,13–18], and only 
two of the seven studies are European [13,15]. Patterns of fragrance consumption may differ around 
the world, and it is mentioned that North European countries consume less fragranced products than 
the southern ones [2]. Only a previous study of this work team was performed in this latter region, 
namely in Portugal [15], and there is not available data about the PCP consumption patterns, mostly 
only the risk of dermal exposure to musks by European children. 
The main purpose of this work was to estimate the risk of children’s dermal exposure to galaxolide 
in Oporto (Portugal). Because of the referred lack of information on the PCP consumer habits and 
PCPs’ fragrance compositions, this particular study intends: (i) to find the most used PCPs among Oporto 
children, concerning moisturizers, toothpastes, bath products, diaper change products, and sunscreens;  
(ii) to quantify the HHCB concentration in each of those PCPs; (iii) to estimate the mean daily 
frequency, quantities, and site of application of each type of PCP in Oporto children, and (iv) to evaluate 
the risk of dermal exposure to HHCB in children. 
2. Experimental Section 
2.1. Questionnaire 
A questionnaire regarding consumer habits (Supplementary File—Questionnaire), previously 
validated with a 50-individual sample, was applied to child caregivers (mothers and fathers) that filled 
out a questionnaire for each child. The inclusion criteria were children aged between 0 and 5 years,  
and resident in the district of Oporto. Based on these inclusion criteria and on the final results of the 
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Portugal Census 2011 [19], the population size was estimated to be 85,019, which corresponds to 30% 
of the population of up to 14 years of age living in the district of Oporto. Thus, with a margin of error 
of 5% and a confidence level of 90%, a sampling size of 270 children was estimated to guarantee 
representativeness of the study. Over 300 questionnaires were delivered on paper from January to 
March 2013 (three months). The questionnaire had a cover page with a brief description of the purpose 
of the study and the possibility of respondents to provide their consent before answering (Supplementary 
File—Questionnaire). Respondents returned the completed questionnaires with no personal 
identification, and a number was attributed to each one, ensuring anonymity. The questionnaire was 
analyzed in terms of social-demographic characteristics and consumer habits, namely most used PCPs 
(brands and types), as well frequency and quantity of application. The PCPs were selected from the 
questionnaires results and complemented with two hypermarkets statistics of sales. 
Besides this information, six of the 250 caregivers agreed to respond to an annex of the 
questionnaire (Supplementary File—Questionnaire) where the used amounts were precisely quantified. 
These responses correspond to the utilization of PCPs by six children aged between 9 and 59 months, 
where half of them were from each gender. For each used PCP, the initial weight of the package was 
recorded as well as the daily frequency of use over seven days, after which the package was weighed 
again. Thus, it was possible to obtain used average quantities for each type of PCP (body moisturizer, 
face moisturizer, toothpaste, bath gel, soap, shampoo, hair conditioner, baby wipes, diaper change 
cream, and sunscreen). Statistical analysis was performed using Microsoft Excel 2007®. 
2.2. Chemicals and Samples 
Based on consumer habits, 79 PCPs were selected as the most used by this population (62 PCPs 
based on the questionnaire results and 17 PCPs from market data obtained from two of the greatest 
hypermarkets chains in the region). These selected PCPs were purchased in pharmacies and 
hypermarkets and the final sample was composed of: twenty one moisturizers, seven toothpastes,  
nine shampoos, thirteen “2 in 1” bath products, two soaps, one cleansing solution, four hair 
conditioners, six baby wipes, eight barrier creams, and eight sunscreens. 
A commercial HHCB standard with a 50% purity in diethyl phthalate (DEP) was purchased from 
SAFC (St. Louis, MO, USA). A working standard solution of HHCB at 60 mg·L−1 was prepared in 
absolute ethanol (pro-analysis grade, from Riedel-de Haën, Honeywell Specialty Chemicals Seelze 
GmbH, Hanover, Germany) for calibration purposes. Stock solutions of HHCB at concentrations 
varying from 455 to 600 mg·L−1 in acetonitrile (HPLC isocratic grade, from VWR International, Radnor, 
PA, USA) and stored in the dark at −4 °C, were used for the spiking of samples for recovery studies. 
The HPLC mobile phase was prepared with deionized water and acetonitrile, acidified with glacial 
acetic acid (100%), and the extraction solvent and sorbents were also the same as described in previous 
work by this team [15]. 
2.3. Extraction and Analytical Method 
The referenced PCPs were extracted by dispersive solid phase extraction, commonly named as 
QuEChERS, and HHCB concentration was determined by High Performance Liquid Chromatography 
with fluorescence detection (HPLC-FL), as described before [15]. At least duplicates of all samples were 
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extracted and analyzed. Briefly, 2 g of samples were rigorously weighed and vigorously shaken for  
3 min with 5 mL of water (co-solvent). Then, 15 mL of acetonitrile (solvent) was added, shaken for 
another 3 min, and homogenized in an ultrasonic bath for 10 min. The two sequential steps of extraction 
and cleanup were performed subsequently adding the corresponding QuEChERS sorbents and mixing, 
as described elsewhere [15]. To enable total phase separation, centrifugation was performed at 3700 rpm 
for 10 min at the end of each of these two steps. The supernatant was collected in a 50 mL PP tube and 
stored in a freezer (−18 °C) until HPLC-FL analysis. Validation parameters of this method were already 
reported in the previously mentioned study [15] and include: a linearity range of 0.005–1.002 mg·kg−1, 
a limit of detection (LOD) of 0.001 mg·kg−1, a repeatability below 11.3%, an intermediate precision of 
2.5% and a global uncertainty below 4% for concentrations under 0.2 mg·kg−1. Accuracy was 
specifically evaluated by the recovery percentage for each type of PCP fortified with HHCB spikes 
(see Section 3.2). 
2.4. Blank Issues/Quality Assurance 
The analyst avoided wearing scented personal products whenever assays were performed. 
Additionally, for each analyzed product, a fresh pair of disposable gloves were used to prevent HHCB 
cross contamination. Glassware was washed using non fragranced detergent and all the materials and 
reagents were tested to be free of interferences, by performing extraction blank assays, as no HHCB 
was detected (below LOD as referred in Section 2.3) as described before [15]. 
3. Results and Discussion 
3.1. Questionnaire 
The aim of this study was to collect information to assess the risk of dermal exposure of children to 
the synthetic fragrance galaxolide contained in toiletries and personal care products. In order to create 
this data pool, a questionnaire for each child was given to caregivers of children aged between 0 and  
5 years, all residents in the Oporto district (inclusion criteria). With these inclusion criteria, the final 
sample size was set at 250 children, corresponding to a representative sample population for a 5.2% 
margin of error and a 90% confidence level. 
3.1.1. Social-Demographic Characterization of Children and Families 
Children Characterization 
Children’s ages were selected assuming a previous reported range [9]. The children were divided 
into six age categories corresponding to each year of life, except for the first year, where the range was 
two half years. This was done because, during the first year, children experience exponential growth 
and major modifications on their skin structure, mainly during the first half year [7,9]. They were aged 
0–5 months (8.3%), 6–11 months (9.1%), 12–23 months (19.0%), 24–35 months (21.3%),  
36–47 months (26.1%), and 48–59 months (16.2%). The distribution of the six age groups by gender is 
shown in Figure 2, where 51% belongs to the female and 47% to the male gender. This distribution is 
according to Portugal Census 2011 [19] for the Oporto district: 52% female and 48% male. 
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Figure 2. Distribution of inquired children by age and gender (total 253 responses). 
The residence area of the inquired children included all 18 municipalities of the Oporto district with 
a distribution that mainly comprises the main city of Porto (26.8%) and also other municipalities like 
Gaia (16.8%), Amarante (15.2%), Matosinhos (10.4%), and Maia (8.8%). This distribution is slightly 
different from the real distribution based on the final results for the northern region of the Portugal 
Census 2011 [19], especially for the municipalities of Amarante and Gondomar. 
Caregivers and Families’ Characterizations 
Most questionnaires (89.2%) were answered by the children’s mothers, 8.8% by the fathers, and 2.0% 
did not answer to this question. The caregivers, with an average of 34.7 ± 4.3 years, are mostly in 
charge with only one child under five years old (79.2%) and have an undergraduate degree (38.0%) or 
a Master’s degree (18.8%), and few (4.0%) have less than six years of schooling (Figure 3). 
 
Figure 3. Qualifications of caregivers. 
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In terms of professional occupation, 20.4% of caregivers work both in the area of “Education” as in 
“Health and social work”, 16.4% in “Other service activities”, and 8.8% in the “Industry”, but 5.2% 
are “Unemployed” (Figure 4). Families are mainly comprised of three (45.0%) or four members 
(44.0%) and most of them (53.6%) reported a monthly income equal or superior to three minimum 
wages, while for 6.4%, monthly income was equal to the minimum wage (about 466 euros/month at the 
time of the study). Nevertheless, 9.2% of the respondents have chosen not to answer to this question. 
 
Figure 4. Caregivers’ professional occupations. 
This section of the questionnaire, corresponding to the characterization of the caregivers and the 
families, was not mandatory, but only a minor fraction of respondents (2.4%) did not answer all of  
these questions. 
3.1.2. Consumer Habits 
The frequency and the mode of application (applied amount and site of application) of the PCPs 
used in children are described in Table 1. Notice that, regarding the mode of application, qualitative 
answers such as “a walnut of product” were inserted in order to facilitate the answers. 
Moisturizing products are applied mostly once (52.8%) or twice (20.8%) a day on the face (92.8%), 
trunk (82.8%) and members (82.4%) as a thick layer (80.8%). Another study about PCP use in children 
in the United States of America (USA), made between 2010 and 2011, reported a similar frequency of 
1.3 times a day for hydration [20]. 
Oral hygiene is performed one (24.0%) or two (46.4%) times a day, applying toothpaste on teeth 
and tongue (52.8%). The used amount of this kind of product corresponds mainly to the nail size of the 
little finger of the child (60.0%). Children who do not use toothpaste (16.4%) are mostly children under 
12 months (15.6%), which is understandable, as most children at this age do not yet have dentition. 
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Table 1. Frequency of utilization, applied amount and site of application of personal care 
products (PCPs) by the inquired children (percentage of answers below). 
Parameters Moisturizer Toothpaste 
Bath 
Gel/Soap 
Shampoo 
Hair 
Conditioner 
Diaper 
Change 
Hygiene 
Diaper 
Change 
Cream 
Sunscreen 
Frequency 
of utilization 
Once a day 
(53%) 
Two times a 
day (46%) 
Once a day 
(68%) 
Once a day 
(41%) 
Once a day 
(10%) 
Five times 
a day 
(mean) 
Five times 
a day 
(mean) 
Three times 
a day * 
(mean) 
Applied 
amount 
Thick layer  
(81%) 
Nail of the  
little finger  
(60%) 
A walnut of 
product  
(74%) 
A walnut of 
product  
(94%) 
A walnut of 
product  
(18%) 
More than  
a wet wipe  
(43%) 
Thick 
layer  
(39%) 
Thick layer 
(51%) 
Site of 
application 
Face  
(93%) 
Teeth and  
tongue  
(53%) 
Wet skin  
(81%) 
Wet scalp 
(92%) 
Hair tips  
(22%) 
Genital 
area  
(43%) 
Irritated 
skin  
(40%) 
All over the 
body  
(66%) 
Note: * On sun exposure days. 
Children usually take a daily bath (68.4%) with application of a walnut of a bath gel (74.4%) 
directly onto wet skin (81.2%). Shampoo is also used on a daily basis by 40.8% of the children,  
while nearly a quarter (24.0%) only uses it three times a week. Typically, a walnut-sized amount of the 
product (93.6%) directly on the scalp (91.6%). This frequency of utilization is consistent with a report 
of 0.7 times a day for bath products and shampoo [20]. Hair conditioner is not used by the majority of 
the population (69.0%). When used, it is done once a day (10.0%) applying a walnut of the product 
(17.6%) at the hair tips (21.6%). 
The diaper change is made from one (20.4%) to six (15.2%) times a day, with an average of five 
times per day, which is higher than the reported three times a day in the already referenced study [20]. 
For the hygiene of the genital area, most parents use one (23.2%) or more (42.8%) baby wipes,  
while others use a cleansing product directly on wet skin (31.6%). The diaper change barrier cream is 
applied as a thin (28.8%) or thick layer (38.8%), all over the genital area (29.6%) or only on irritated 
skin patches (40.0%). 
Only a minority (8.0%) of the analyzed children do not use sunscreen, but all of them are children 
under 12 months of age, which is in fact an age group where any sun exposure should be avoided.  
The vast majority of the parents said they do not apply sunscreen every day of the year (83.6%), 
applying only in days of sun exposure, two (22.0%), three (26.4%) or four (20.4%) times a day, with 
an average of 3 times per day. The product is usually applied all over the body (65.6%) in a thin 
(32.8%) or thick layer (50.8%). 
Based on the questionnaire results, 62 PCPs were selected as the most used by this population,  
and 17 other were added based on the sales statistics from two local hypermarkets (Table 2).  
These final 79 analyzed products were: twenty one moisturizers, seven toothpastes, thirteen bath gels, 
two soaps, one cleansing solution, nine shampoos, four hair conditioners, six baby wipes, eight diaper 
change creams, and eight sunscreens. 
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Table 2. Selected personal care products (PCP) based on the level of use (%) obtained in 
the questionnaires or from hypermarket statistics; respective galaxolide (HHCB) 
concentrations (highest concentrations in bold) and PCP presentation. 
PCP Type PCP Code 
PCP Utilization 
(%) 
HHCB Concentration  
(mg·kg−1 Sample) 
PCP 
Presentation 
Moisturizers 
(N = 70) 
M1LC1 0.3 0.098 ± 0.007 Lotion 
M2CC1 0.5 0.022 ± 0.009 Cream 
M3LC2 0.8 414.855 ± 0.016 Lotion 
M4CC2 0.8 0.220 ± 0.009 Cream 
M5CR1 1.8 0.024 ± 0.007 Cream 
M2CC3 1.8 0.169 ± 0.010 Cream 
M6CC4 2.1 0.362 ± 0.012 Cream 
M2CC5 2.6 0.018 ± 0.011 Cream 
M7LC3 3.2 0.032 ± 0.009 Lotion 
M2CR2 3.9 0.034 ± 0.007 Cream 
M7LC4 4.7 0.406 ± 0.010 Lotion 
M2CC6 4.7 0.058 ± 0.007 Cream 
M8CC7 5.0 nd Cream 
M5CC8 6.1 0.020 ± 0.011 Cream 
M9CC9 7.4 0.013 ± 0.011 Cream 
M4CR3 7.4 105.397 ± 0.030 Cream 
M4LC5 11.3 184.174 ± 0.034 Lotion 
M2LC6 15.0 nd Lotion 
M5LC7 a 0.031 ± 0.010 Lotion 
M5LC8 a 0.023 ± 0.011 Lotion 
M7LC9 a 0.114 ± 0.008 Lotion 
Other PCPs (n = 49) 20.5 – – 
No answer; Don’t Know/use 1.1 – – 
Toothpastes 
(N = 24) 
M10GD1 2.6 nd Gel 
M10GD2 2.6 0.056 ± 0.001 Gel 
M11PD1 9.8 0.009 ± 0.008 Paste 
M12GD3 10.9 nd Gel 
M13GD4 18.9 0.006 ± 0.006 Gel 
M14PD2 22.3 0.014 ± 0.010 Paste 
M15GD5 a nd Gel 
Other PCPs (n = 17) 12.8 – – 
No answer; Don’t Know/use 20.1 – – 
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Table 2. Cont. 
PCP Type PCP Code 
PCP Utilization 
(%) 
HHCB Concentration  
(mg·kg−1 Sample) 
PCP 
Presentation 
Body Bath Products 
(N = 58) 
M16SB1 0.7 300.480 ± 0.017 Soap 
M17GB1 1.0 1.385 ± 0.033 Gel 
M18SB2 1.0 0.712 ± 0.012 Soap 
M7GB2 3.5 0.033 ± 0.006 Gel 
M4GB3 4.5 79.718 ± 0.019 Gel 
M9GB4 5.6 0.035 ± 0.007 Gel 
M2SL1 8.0 0.075 ± 0.007 Solution 
M4GB5 8.4 0.063 ± 0.007 Gel 
M5GB6 9.1 0.025 ± 0.009 Gel 
M7GB7 10.5 0.100 ± 0.009 Gel 
M2GB8 24.0 0.444 ± 0.012 Gel 
M1GB9 a 0.010 ± 0.009 Gel 
M1GB10 a 0.068 ± 0.002 Gel 
M5GB11 a 0.012 ± 0.010 Gel 
M7GB12 a 0.226 ± 0.009 Gel 
M3GB13 a 217.795 ± 0.012 Gel 
Other PCPs (n = 42) 23.3 – – 
No answer; Don’t Know/use 0.3 – – 
Shampoos 
(N = 25) 
M19CH1 1.7 0.038 ± 0.007 Gel 
M5CH2 10.4 0.193 ± 0.010 Gel 
M4CH3 10.4 127.517 ± 0.030 Gel 
M7CH4 52.2 0.005 ± 0.005 Gel 
M1CH5 a 0.035 ± 0.006 Gel 
M1CH6 a 0.796 ± 0.019 Gel 
M7CH7 a 0.089 ± 0.008 Gel 
M7CH8 a 0.346 ± 0.010 Gel 
M7CH9 a 0.209 ± 0.010 Gel 
Other PCPs (n = 16) 0.9 – – 
No answer; Don’t Know/use 24.3 – – 
Hair Conditioners  
(N = 8) 
M20AS1 5.9 251.796 ± 0.031 Solution 
M7AC1 64.7 0.037 ± 0.006 Cream 
M7AC2 a 0.017 ± 0.011 Cream 
M7AS2 a 0.006 ± 0.006 Solution 
Other PCPs (n = 4) 23.5 – – 
No answer; Don’t Know/use 5.9 – – 
Baby Wipes 
 (N = 26) 
M17TL1 0.7 2.675 ± 0.009 Wet wipe 
M7TL2 3.0 nd Wet wipe 
M4TL3 3.3 nd Wet wipe 
M8TL4 4.6 0.001 ± 0.001 Wet wipe 
M21TL5 6.3 0.022 ± 0.011 Wet wipe 
M22TL6 43.4 0.154 ± 0.010 Wet wipe 
Other PCPs (n = 20) 17.4 – – 
No answer; Don’t Know/use 21.4 – – 
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Table 2. Cont. 
PCP Type PCP Code 
PCP Utilization 
(%) 
HHCB Concentration  
(mg·kg−1 Sample) 
PCP 
Presentation 
Diaper Change 
Products  
(N = 28) 
M2CF1 1.1 nd Cream 
M23CF2 1.4 0.012 ± 0.011 Cream 
M5CF3 3.2 0.207 ± 0.008 Cream 
M24PO1 4.9 1.234 ± 0.025 Ointment 
M2PA1 5.6 0.016 ± 0.011 Paste 
M4CF4 6.0 71.513 ± 0.010 Cream 
M6PA2 15.1 0.016 ± 0.011 Paste 
M23PO2 21.1 nd Ointment 
Other PCPs (n = 20) 18.3 – – 
No answer; Don’t Know/use 23.2 – – 
Sunscreens 
 (N = 31) 
M25PL1 5.2 0.074 ± 0.006 Lotion 
M4CM1 6.6 1.005 ± 0.023 Paste 
M26PL2 9.0 12.312 ± 0.010 Lotion 
M2PL3 9.4 0.051 ± 0.007 Lotion 
M2CM1 11.5 0.344 ± 0.010 Paste 
M27PL4 12.8 0.229 ± 0.010 Lotion 
M27CM2 15.3 0.394 ± 0.011 Paste 
M1PL5 a 134.715 ± 0.025 Lotion 
Other PCPs (n = 23) 21.9 – – 
No answer; Don’t Know/use 8.3 – – 
Notes: a Indicated by hypermarkets statistics; nd not detectable. 
3.2. HHCB Concentrations 
The final results for the analyzed PCPs are presented in Table 2. Product brands and designations 
were encoded as a PCP code representing the number of the mark (M#) followed by a product number 
according to the presentation and use of that product. For example, brand 1 has a body lotion  
(M1LC1), two bath gels (M1GB9, M1GB10), two shampoos (M1CH5, M1CH6) and a sunscreen 
lotion (M1PL5). 
HHCB was detected in 70 of the 79 analyzed PCPs, within a wide range of concentrations that  
were consistent with other studies, although all of them respective PCPs for adults [3,13–17].  
The HHCB concentrations ranged from 0.001 ± 0.001 mg·kg−1, on a baby wipe (M8TL4)  
to 300.480 ± 8.819 mg·kg−1, on glycerin soap (M16SB1). The highest HHCB concentrations were 
found in ten products (bold PCP codes in Table 2), and five of them are from brand M4 (with nine 
analyzed products). The nine products with concentrations of HHCB below the limit of detection  
(LOD = 0.001 mg·kg−1 sample) are indicated as not detectable (nd) in Table 2 and two of them are from 
brand M2 (with twelve analyzed products). In this study, 29 of the analyzed PCPs were labeled as 
“fragrance-free”, but only six of them have actually a non-detectable amount of HHCB. Among these 
“fragrance-free” products, the detectable HHCB concentrations varied between 0.001 ± 0.001 and  
71.513 ± 0.010 mg·kg−1, and therefore, most of them cannot be considered as residual quantities. On the 
other hand, three of the 50 PCPs that include “parfum” or “fragrance” in their compositions, were 
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found to have no detectable HHCB, indicating that those products may contain other fragrance 
ingredients, rather than HHCB. 
All presented concentrations were corrected by their respective recovery (Table 3), determined  
as described before [15], and ranging from 65% in lotion moisturizers and sunscreens (with a  
320.0 mg·kg−1 sample spike) and 98% in soaps (with a 227.5 mg·kg−1 sample spike) and creams (with 
a 300.0 mg·kg−1 sample spike). 
Table 3. Selected personal care products (PCP) for the recovery assays of each PCP 
category, respective galaxolide (HHCB) concentrations, HHCB spikes, and recoveries (%). 
PCP Category 
PCP 
Presentation 
PCP Code 
HHCB 
Concentration 
(mg·kg−1 Sample) 
HHCB 
Concentration Spike  
(mg·kg−1 Sample) 
HHCB 
Recovery 
(%) 
Moisturizers 
Lotion M7LC3 0.032 ± 0.009 320.0 65 
Cream M4CR3 105.397 ± 0.030 300.0 98 
Toothpastes 
Paste M14PD2 0.014 ± 0.010 300.0 80 
Gel M15GD5 nd 227.5 80 
Body Bath 
Products 
Soap M16SB1 300.480 ± 0.017 227.5 98 
Solution M2SL1 0.075 ± 0.007 230.0 85 
Gel M1GB9 0.010 ± 0.009 230.0 84 
Shampoos Gel M4CH3 127.517 ± 0.030 300.0 81 
Hair 
Conditioners 
Cream M7AC2 0.017 ± 0.011 227.5 75 
Baby Wipes Wet wipe M17TL1 2.675 ± 0.009 227.5 68 
Diaper Change 
Products 
Paste M27CM2 0.394 ± 0.011 230.0 79 
Ointment M24PO1 1.234 ± 0.025 320.0 70 
Sunscreens 
Lotion M7LC3 0.032 ± 0.009 320.0 65 
Paste M27CM2 0.394 ± 0.011 230.0 79 
Note: nd not detectable. 
3.3. HHCB Risk of Dermal Exposure 
Considering children’s consumer habits previously obtained by the referenced questionnaire,  
an estimation of the total daily dermal exposure to HHCB of this population was performed (Table 4). 
The mean daily application amount was estimated based on the responses obtained from the 
questionnaire annex (Supplementary File—Questionnaire). Average retention factors on skin for each 
type of PCP were based on values reported in scientific literature [21] for similar products: 100% for 
leave-on products (body lotions, creams, wet wipes, and sunscreens) and 10% for rinse-off products 
(toothpastes, bath gels, soap bars, shampoos, and hair conditioners). The mean daily HHCB retention 
for each type of PCP was calculated as the product of mean HHCB concentrations on each group 
(considering measured concentrations in Table 2), mean daily applied amount, and the respective 
retention factor. Total daily dermal exposure risk was obtained by the sum of all HHCB retained from 
daily use of PCPs. 
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Table 4. Estimated mean daily dermal exposure to HHCB (µg·day−1) using the analyzed PCPs. 
Personal Care 
Products 
(PCPs) 
Application 
Site 
Exposure 
Route 
Number of 
Analyzed 
PCPs 
Mean HHCB 
Concentration c 
(mg·kg−1 Sample) 
Mean daily 
Application 
Amount  
(g·Sample·day−1) 
Retention 
Factor (%)  
[21] 
Mean Daily 
HHCB 
Retention 
(µg·day−1) 
Body lotions/ 
creams 
Whole body Dermal 18 37.539 1.4 100.0% 52.5541 
Facial creams Face Dermal 3 35.152 0.5 100.0% 17.5759 
Toothpastes 
Perioral region 
and mouth 
mucous 
membranes 
Dermal 
and oral 
7 0.021 0.2 10.0% 0.0004 
Bath gels Whole body Dermal 14 21.428 2.1 10.0% 4.4998 
Soap bars Hands Dermal 2 150.431 1.1 10.0% 16.5474 
Shampoos 
Scalp, neck 
and hands 
Dermal 9 14.359 0.9 10.0% 1.2923 
Hair 
conditioners 
Hair tips and 
hands 
Dermal 4 62.964 0.6 10.0% 3.7779 
Baby wipes a Genital area Dermal 6 0.713 21.7 100.0% 9.9853 
Diaper change  
creams 
Genital area Dermal 8 12.167 0.7 100.0% 8.5166 
Sunscreens b Whole body Dermal 8 18.672 8.4 100.0% 156.8443 
Total daily dermal exposure to HHCB (µg·day−1) 277.10 ± 0.02 
Notes: a mean daily application calculated based on the questionnaire annex answers that indicate an average 
of 7 baby wipes a day and about 3.1 g each wipe; b mean daily application calculated assuming a sun 
exposure day (3 times a day in thick layer, Table 1); because no answers were obtained for the annex to the 
questionnaire related to sunscreens, the application of a thick layer was assumed to be twice the amount of 
body lotions/creams (thin layer); c Mean HHCB concentrations for all the analysed PCPs in each category of 
products (Table 2). 
The lowest mean HHCB concentrations (Table 4) were found in toothpastes and baby wipes,  
while the highest mean concentration corresponded to soap bars. Soap bars can irritate the skin due to 
its alkaline pH and due to the presence of some additives, like fragrances [11], which can raise the risk 
of exposure to HHCB. Nevertheless, these kind of PCPs were not the most relevant ones to the 
estimated total daily dermal exposure risk, as soap bars were only considered to be used for washing 
hands, and, therefore, used on a reduced exposure area. In cases where they are used for body wash, 
their influence to dermal exposure may be higher. The highest contribution for the estimated dermal 
exposure risk, then, was found to be from leave-on-products applied onto the whole body (Table 4): 
sunscreens, assuming a sun exposure day, and body lotions/creams, on the other days. Additionally,  
it is expected that penetration is greater for longer contact times and surface areas [22]. Consequently, 
leave-on-products applied onto the whole body, like moisturizers and sunscreens, should be the most 
absorbed ones. It is also reported that the penetration varies with the application site of the PCP,  
of which the most critical ones are the genitals, head and trunk [23], so only this last site could more 
greatly affect the dermal exposure risk from moisturizers and sunscreens. Toothpastes were the PCPs 
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that contributed less to the total dermal exposure risk, which is consistent with the small area of the 
oral cavity, small applied quantities, short contact time, and low detected HHCB concentrations found 
in these kind of products (some not detectable). Nevertheless, it should be noted that there is still some 
risk of oral exposure from toothpastes, although this is not a major route. 
The estimated total daily dermal exposure to HHCB was 277.10 ± 0.02 µg·day−1 (Table 4) 
considering the mean application amount for each kind of PCP used by all the children’s age groups. 
Observing data in detail and the differences between the youngest and the oldest children consumer 
habits, we can notice that the total daily dermal exposure risk is about 132.38 ± 0.01 µg·day−1 for 
children less than 1 year old and 169.16 ± 0.02 µg·day−1 for children older than 4 years. The lower 
levels for these two age groups, at the lower and upper end of the studied population, are justified by 
the fact that the youngest ones do not yet use sunscreens (46.5%) or toothpastes (81.4%), while the 
oldest ones use no more diaper change products (53.7%). The middle-aged groups have a higher mean 
daily dermal exposure risk to HHCB (297.98 ± 0.02 µg·day−1) because they already use sunscreens 
and still use considerable amounts of diaper change products. All of the estimated daily dermal 
exposure risks are below other published results for adults (904 µg·day−1 [15] (3060 µg·day−1 [14], 
25,100 µg·day−1 [3] and 23,700 µg·day−1 [13]), which is consistent with the fact that children’s PCPs 
are expected to be less fragranced than adult’s ones and the used amounts are also smaller in children. 
Although rather small amounts are predicted to be retained by children’s skin, exposure risk can be 
higher than in adults, especially when the epidermal barrier is compromised due to some common 
children’s skin disorders. To the authors’ best knowledge, no studies were found about children’s 
dermal exposure to HHCB, but a study in the elderly population, with an altered epidermal barrier, 
showed a higher systemic absorption of musks than in healthy adults [12]. A common children’s skin 
disorder that may alter epidermal barrier is atopic skin, but it should be mentioned that the six analysed 
body creams for this kind of skin have a mean HHCB concentration value of 0.134 mg·kg−1 sample, 
which is a low contribution for dermal exposure to HHCB in children. 
Considering the estimated total daily dermal exposure risk to HHCB and a total evaporation factor 
of 22% [24], only 216 µg·day−1 remains on the skin surface and may be absorbed. There is limited 
information about HHCB dermal absorption, but the human skin absorption has been reported as 
19.5%, of which only 0.1% eventually enters the systemic circulation [24]. However, different rates 
are expected when dealing with children or baby skin [7–9]. Considering the same level of absorption 
for all PCPs for children and adults, and assuming an average body weight (BW) of 17.2 kg for a  
4-year-old child [25], dermal exposure will be about 0.02 µg·kg·BW−1·day−1. To the author’s best 
knowledge, no other values of dermal exposure of children to HHCB due to PCP use was reported. 
Only one study was found where dermal exposure of children to toys scented with several fragrances was 
evaluated and reported values were significantly higher, ranging from 8.6 to 605.0 µg·kg·BW−1·day−1 [25]. 
4. Conclusions 
PCP consumption habits of children population from the Oporto district was established  
by a questionnaire applied to 250 children. The frequency and mode of application of the PCPs, 
estimated by the results of this survey, permitted to establish the common applied quantities. 
Additionally, HHCB was detected in 70 of the 79 most used PCPs in concentrations ranging  
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from 0.001 ± 0.001 mg·kg−1, found on a baby wipe, and 300.480 ± 8.819 mg·kg−1, detected in glycerin 
soap. The frequency and mode of application of the PCPs, estimated by the results of this survey, 
permit researchers to establish the common applied quantities. With these results, it was possible to 
determine the children’s dermal exposure to HHCB from personal care products in Oporto as  
277.10 ± 0.02 µg·day−1. 
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